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We have isolated and sequenced 3 human DNA topoisomerase II (topo II) partial eDNA clones from a HeLa carcinoma cell eDNA library. Two 
clones were identical to an internal fragment of HeLa topo II eDNA. The third clone, CAA5, had a different and novel sequence which shared 
significant nucleotide (62%) and predicted peptide (70%) homologies with a region of the HeLa topo II eDNA. Our results uggest that HeLa cells 
express at least two homologous forms of DNA topoisomerase II. The new HeLa topo II homologne isdiscussed in relation to topo II isoenzymes 
recently described in a Burkitt lymphoma nd other cell lines. 
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1. INTRODUCTION 
DNA topoisomerase II (EC 5.99.1.3; topo II) is an 
important nuclear scaffold protein implicated in key 
biological processes including DNA replication and 
chromosome segregation [1-3]. The enzyme is a 
homodimer that acts to pass a duplex DNA segment 
through a transient enzyme-bridged double strand 
break in DNA [3,4]. Several clinically useful anticancer 
agents, e.g. etoposide and doxorubicin, appear to exert 
their cytotoxic effects by interfering with this enzymatic 
DNA breakage-reunion reaction [5]. 
Human topo II was first purified as a 170 kDa 
polypeptide (p170) from the HeLa cervical carcinoma 
cell line for which Wang and colleagues reported the 
cDNA sequence, and we in parallel obtained a 
homologous partial eDNA clone (CAA1) [6,7]. 
However, very recent work has demonstrated the 
presence in the Burkitt lymphoma cell line Raji of two 
isoenzyme forms of topo II: IIo~, analogous to p170 in 
HeLa cells, and a 180 kDa form, termed Ilfl or plB0 [8]. 
Analysis of partial cDNA clones isolated from a Raji 
library indicated that these proteins derive from, two 
different mRNA species which are differentially ex- 
pressed in the cell cycle [9]. 
During the course of eDNA cloning studies using 
CAA1 as a hybridization probe, we isolated a novel 
human HeLa cDNA clone that encodes an as yet 
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unreported topo II-related polypeptide. In light of cur- 
rent interest in different forms of topo II and their 
biological roles, we describe here the initial 
characterization of the novel eDNA and its relationship 
to cDNAs for the human p170 and plB0 topo II isoen- 
zymes. 
2. EXPERIMENTAL 
2.1. cDNA cloning 
A human HeLa cell ~,gtl0 eDNA library was obtained from Dr D. 
Gewert. It was constructed by oligo dT priming of mRNA (isolated 
from interferon-treated HeLa ceils) and the resulting cDNAs were 
cloned into )~gt 10 using EcoRI linkers. The library was screened under 
conditions of low stringency with a partial eDNA clone (CAAI) en- 
coding part of the C-terminal region of the piT0 form of human 
topoisomerase I1 [7]. CAA1 was isolated by cross-species xpression 
screening of a HepG2 )~gtll library and spans a 231 base pair (bp) 
region between ucleotide positions 3495 and 3726 of the 4753bp 
eDNA sequence [6,7]. Hybridisation was carried out at 42°C in buffer 
containing 6x SSC, 5 x Denhardts, 0.5070 sodium dodecyl sulphate, 
100/~g/ml denatured salmon sperm DNA and 8°70 dextran sulphate. 
Positive clones were plaque purified by at least 3 successive rounds of 
screening. Phage )~DNA was isolated as described [10]. 
2.2. DNA sequence analysis 
Insert DNA from ~,gtl0 clones released by digestion with EcoRI, 
was purified by eiectrophoresis in a 2070 low gelling agarose gel 
(Sigma) and isolated on NA45 paper (Schleicher and Schuell). Insert 
DNA or fragments arising from digestion with HaelII or BgllI were 
ligated into appropriately cut M 13mpl0 and mpl 1 RF DNA and used 
to transform E. coli XL1 recA. Single stranded recombinant MI3 
DNA was purified and sequenced by the Sanger dideoxy method using 
either Klenow fragment (Amersham) or Sequenase II (United States 
Biochemical Corp.). Sequence information was analysed using the 
Genofit/PC Gene Package (Inteiligenetics). 
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3. RESULTS 
3.1. Isolation of cDNA clones homologous to human 
p170 DNA topoisomerase H 
Screening of a HeLa ~,gtl0 cDNA library with the 
partial p170 topo II cDNA CAA1 yielded 3 positive 
clones, two of which had an identical 1.7 kb EcoRI in- 
sert (CAA4) while the third contained a 700 bp insert 
(CAA5) (Fig. 1). The restriction map of CAA4 was 
identical to part of p170 topo II cDNA (Fig. 1) and this 
identification was confirmed by DNA sequence 
analysis. CAA4 spans nucleotide positions 2014-3698 
of p170 topo II cDNA encoding amino acid residues 
660-1220 of the 1530 residue protein. The probe CAA1 
is therefore identical to the 3' end of clone CAA4 (Fig. 
1). 
The second type of cDNA clone, CAA5, isolated at 
the same time under the same conditions as CAA4, had 
a different restriction map to those of CAA4 and p170 
cDNA (Fig. 1) and suggested it may encode a 
homologous but novel form of DNA topoisomerase II.
3.2. Protein encoded by the novel human cDNA CAA5 
aligns and shares substantial homology with 
human p170 topo H 
The 702 bp nucleotide sequence of CAA5 was deter- 
mined and found to exhibit 62% homology with a seg- 
ment of the p170 topo II cDNA - nucleotide positions 
3062-3764 (Figs 1, 2). CAA5 has a single uninterrupted 
open reading frame encoding a 234 amino acid residue 
polypeptide (Fig. 2B). The CAA5 protein sequence 
aligns with residues 1021-1253 of p170 topo II display- 
ing a 70% overall homology (58% identical residues 
and 12% conserved residues) (Fig. 3). Homology with 
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Fig. 1. Restriction maps and alignment of topo II cDNA clones, pl70 
and p180 isoenzyme maps were generated from DNA sequence in 
references [6] and [9]. E, H and B denote restriction sites for EcoRI, 
HaeIII and BglII. CAA1 and CAA4 are identical with p170 cDNA 
between the indicated nucleotide positions. CAA5 and p 180 are align- 
ed by their respective homology with the p170 cDNA sequence. 
A 
EcoRl EcoRl 
Haelll Bglll 
I 295 423 7(]2 
Es 
20 40 
TT C~AT~A CG ATTAAGTTATTA CGGT~A CGTAAGGAGTGG CT~TGGGAATG TTG 
F F D L R L S ¥ ¥ G L R K E W L V G M L 
80 I00 
GGAGCAGAATCTACAAAGCTTAACAATCAAGCCCGTTTCATTTTAGAGAAGATACAAGGG 
G A E S T K L N N O A R F I L E K I Q G 
140 160 
AAAATTACTATAG AGAATAGGTCAAAGAAAGATTTGATTCAAATGTTAGTCCAGAGA GGT 
K I T l E N R S K K D L I Q M L V Q R G 
200 220 
TATGAAT CTGACCCAGTG AAAG CCTGGAAAGAAG CACAAGAAAAGG CAGCAGAAGAGGAT 
Y E S D P V K A W K E A Q E K A A E E D 
260 280 
GAAACACAAAACCAGCATGATGATAGTTCCTCCGATTCAGGAACTCCTTCAGGCCCAGAT 
E T Q N Q H D D S S S D S G T P S G P D 
320 340 
TTTAATTATATTTTAAATATGTCTCTG TGGTCTCTTA CTAAAGAAAAAGTTGAAGAA CTG 
F N Y I L N M S L W S L T K E K V E E L 
380 400 
ATTAAAC AGAGAGATG CAAAAG GG CGA GAGG T CAATGATCTTAAAAGAAAATCTCCTTCA 
I K Q R D A K G R E V N D L K R K S P S 
440 460 
G ATCT~GGAAAGAGGATTTAG CGG CATTTG TTGAAGAACTGGATAAAGTGGAATCTCAA 
D L W K E D L A A F V E E L D K V E S Q 
500 520 
G AACGAGAAGATGTTCTGGCTGGAATGTCTGGAAAAGCAATTAAAGGTAAAGTTGG CAAA 
E R E D V L A G M S G K A I K G K V G K 
560 580 
C CTAAG GTGAAGAAACT CCAG TTGG AAGAG A CAATG CC CTCACCTTATGGCAGAAGAATA 
P K V K K L Q L E E T M P S P Y G R R I 
620 640 
A TT CCTGA~TTACAG CTATG AAGGCAGATGCCAG CA~GTTG CTG AAGAAGAAGAAG 
I P E I T A M K A D A S K K L L K K K K 
680 700 
GGTGATC~GATACTGCAGCAGTA~GTGGAAT~GATGAA 
G D L D T A A V K V E F D E 
Fig. 2. DNA sequence analysis of CAA5, a topo II-related HeLa 
cDNA. (A) DNA sequencing strategy. (B) Nucleotide sequence of 
CAA5 and the derived amino acid sequence of its single open reading 
frame. 
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Fig. 3. Alignment of the predicted amino acid sequence of CAA5 (top 
line) with that of p170 topo II [6] showing identical (:) and conserved 
residues (-). Amino acid residues conserved between CAA5 and 
Drosophila topo II [11] are overlined. 
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p170 topo II is especially marked at the N-terminal end 
of the CAA5 polypeptide: ofthe first 81 residues, 62 are 
identical and a further 10 are conserved substitutions. 
Significant homology at the protein level is also observ- 
ed between CAA5 and the appropriate r gion of topo II 
from other species including Drosophila (Fig. 3) and 
yeast (not shown). Comparison of CAA5 with the 
recently published partial cDNA and protein sequence 
of the human p180 topo II isoenzyme [9] (Fig. 1) did not 
reveal significant homology (not shown). 
4. DISCUSSION 
Topo II from HeLa cells has previously been isolated 
only as a 170 kDa polypeptide form [4]. The correspon- 
ding cDNA has been described and the suggestion made 
that HeLa topo II is encoded by a single copy gene, 
mapped to chromosome 17 [6]. Our cDNA cloning 
studies reported here indicate that HeLa cells also ex- 
press another protein, partially encoded by CAA5, that 
exhibits remarkable sequence conservation with p170 
topo II and other eukaryotic topo II enzymes and in- 
deed may represent a distinct human isoenzyme form. 
At present, we do not know whether the 
CAA5-encoded protein is the same as or different from 
the p180 topo II isoenzyme described in Raji cells [8]. 
The longest partial cDNA clone (SPll) for p180 
isolated from a nitrogen mustard resistant Raji line, ap- 
pears to encode the N-terminal region of the protein, 
judged by its homology to nucleotide region 379-3065 
of the p170 topo II cDNA (Fig. 1) [5,9]. In contrast, 
CAA5 encodes protein sequence homologous to the C- 
terminal end of p170 topo II and does not overlap that 
determined for p180 (Fig. 1). 
It is interesting, however, that the p180 and CAA5 se- 
quences are homologous to directly adjacent regions of 
p170 topo II, each sequence terminating at an EcoRI 
site in the respective cDNA (Fig. 1). The derived amino 
acid sequence for p180 topo II reported by Chung et al. 
[9] finishes at a position equivalent to residue 1021 of 
the p170 form (terminating in the cDNA at a natural 
EcoRI site) while that from CAA5 is homologous to 
p170 residues 1021-1253 (Fig. 1). Thus, the p180 and 
CAA5 partial cDNA clones could correspond to con- 
tiguous EcoRI cDNA fragments. Conceivably, CAA5 
encodes a C-terminal segment of the p180 topo II isoen- 
zyme. 
Chung et al. isolated their Raji p180 topo II partial 
cDNA clone by screening with a probe encoding 
Drosophila topo II [9]. In contrast, CAA5 was obtained 
using a C-terminal human HeLa topo II probe (Fig. 1). 
It is known that HeLa, Drosophila and other 
eukaryotic topo II cDNA sequences are closely 
homologous in the N-terminal two thirds of the coding 
sequence whereas nucleotide sequences for the C- 
terminal regions are more divergent [11]. These con- 
siderations may explain why the different screening ap- 
proaches yielded topo II-related cDNA clones that align 
with different ends of the HeLa p170 cDNA sequence. 
Topo II p170 and p180 isoenzymes have been 
detected incell extracts from a number of sources in ad- 
dition to Raji cells including human U937 monocyte 
and COLO 201 colon carcinoma cell lines and in murine 
P388 leukaemia nd NIH 3T3 fibroblast cell lines [9]. 
HeLa p170 topo II was isolated before the existence of 
isoenzyme forms was generally recognized. It will now 
be important o examine HeLa cell extracts for the 
presence of other topo II proteins, e.g. p180. 
The physiological and chemotherapeutic roles of 
topo II isoenzymes are of great interest and remain to 
be elucidated. Further work is in progress to 
characterise fully the structure, expression and 
biological function of the novel CAA5 encoded HeLa 
protein. 
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